aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Mersana Therapeutics is dedicated to discovering and developing life-changing antibody-drug conjugates (ADCs) for cancer patients. The company specializes in innovative ADC platforms with cytotoxic and immunostimulatory payloads, allowing for customization and optimization to enhance efficacy and tolerability. Mersana focuses on creating oncology agents to treat tumors and cancer, serving the healthcare industry in the United States.
Mersana has achieved significant advancements with its differentiated ADC platforms, aiming to overcome the limitations of first-generation technologies. The company's innovative approach has positioned it as a leader in the development of novel cancer therapies. Through its cutting-edge research and development, Mersana continues to make a substantial impact on the treatment of cancer, offering hope to patients worldwide.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Oncology Agents
Technology
Biotech
Tags
Healthtech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Mersana Therapeutics founded?
Mersana Therapeutics was founded in 2001.
Where is Mersana Therapeutics’s headquarters located?
Mersana Therapeutics’s headquarters is located in Cambridge, CAM, GB.
When was Mersana Therapeutics’s last funding round?
Mersana Therapeutics’s most recent funding round was for $100M (USD) in January 2021.
How many employees does Mersana Therapeutics have?
Mersana Therapeutics has 228 employees as of Feb 6, 2024.
How much has Mersana Therapeutics raised to-date?
As of July 05, 2023, Mersana Therapeutics has raised a total of $655.6M (USD) since Jan 1, 2021.
Add Comparison
Total Raised to Date
$655.6M
USD
Last Update Jan 1, 2021
Last Deal Details
$100M
USD
Jan 1, 2021
Post Ipo Debt
Total Employees Over Time
228
As of Feb 2024
Mersana Therapeutics Address
Cambridge,
Cambridgeshire
United Kingdom
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts